CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 45 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $60,000 | -28.6% | 13,326 | -16.3% | 0.00% | 0.0% |
| Q4 2015 | $84,000 | +7.7% | 15,926 | +18.2% | 0.00% | 0.0% |
| Q3 2015 | $78,000 | -80.6% | 13,472 | -76.1% | 0.00% | -73.3% |
| Q2 2015 | $403,000 | +150.3% | 56,300 | +132.6% | 0.02% | +150.0% |
| Q1 2015 | $161,000 | -54.5% | 24,201 | -59.0% | 0.01% | -76.0% |
| Q4 2014 | $354,000 | +21.6% | 58,968 | 0.0% | 0.02% | +66.7% |
| Q3 2014 | $291,000 | +5.1% | 58,968 | -4.1% | 0.02% | +25.0% |
| Q2 2014 | $277,000 | -0.7% | 61,518 | -0.7% | 0.01% | -40.0% |
| Q1 2014 | $279,000 | -2.1% | 61,950 | +11.2% | 0.02% | -13.0% |
| Q4 2013 | $285,000 | +25.0% | 55,695 | +10.5% | 0.02% | +27.8% |
| Q3 2013 | $228,000 | -20.8% | 50,395 | -10.5% | 0.02% | -47.1% |
| Q2 2013 | $288,000 | – | 56,295 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $541,778 | 0.01% |
| Renaissance Technologies | 555,763 | $1,050 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $5,768 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $354 | 0.00% |
| MORGAN STANLEY | 11,274 | $21,308 | 0.00% |
| BlackRock Inc. | 110,990 | $209,771 | 0.00% |
| Bank of New York Mellon Corp | 75,268 | $142,256 | 0.00% |
| Citadel Advisors | 32,400 | $61,236 | 0.00% |
| Citadel Advisors | 6,400 | $12,096 | 0.00% |
| Citadel Advisors | 5,933 | $11,213 | 0.00% |